NICOLE BROWN: Open Payments
NPI 1558906750 · PERRYVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 26 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $161 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $65 |
| Lilly USA, LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Medtronic, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: REXULTI, Ozempic, MOUNJARO, CAPLYTA, INCEPTIV, UBRELVY, AUSTEDO XR, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
